First use of GdDTPA/dimeglumine in man.
The dimeglumine salt of the Gd-DTPA complex has a strong paramagnetic effect and a very low toxicity in animals. This report of its use in human volunteers confirms its low toxicity and indicates its usefulness in the enhancement of signal intensity of the kidney and bladder.
D000328:Adult; D003287:Contrast Media; D004341:Drug Evaluation; D005682:Gadolinium; D006801:Humans; D007668:Kidney / Q000032:analysis; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008536:Meglumine / Q000633:toxicity; D004369:Pentetic Acid / Q000633:toxicity; D013012:Sorbitol / Q000031:analogs & derivatives*; D001743:Urinary Bladder / Q000032:analysis
D003287:Contrast Media; D013012:Sorbitol; D008536:Meglumine; D004369:Pentetic Acid; D005682:Gadolinium